A detailed history of Sih Partners, Lllp transactions in Mannkind Corp stock. As of the latest transaction made, Sih Partners, Lllp holds 19,132 shares of MNKD stock, worth $82,267. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,132
Holding current value
$82,267
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$4.92 - $6.6 $94,129 - $126,271
19,132 New
19,132 $96.2 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.11B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Sih Partners, Lllp Portfolio

Follow Sih Partners, Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sih Partners, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Sih Partners, Lllp with notifications on news.